The global animal intestinal health market size is expected to reach USD 7.40 billion by 2030, at a projected CAGR of 7.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. Primary market growth drivers include rising R&D initiatives and the emergence of substitute products for animal intestinal health. Key industry participants are engaging in research activities to approach intestinal health complications in a more structured and scientific manner by creating knowledge bases and recommendations for both veterinarians & animal owners. This will boost the innovative spirit of the market and assist in the development of novel products that enhance the current gut health treatment regimes.
For instance, in April 2024, Nestle introduced the Petivity Microbiome Analysis Kit, which employs stool samples to provide customized information regarding the gut health of companion animals such as dogs and cats. This makes it possible for the experts to modify the nutrition and supplements according to every pet's microbiome. With more than a decade of research behind it, the kit makes assumptions about the health of the pet's digestive system. These developments offer proactive solutions for professionals seeking ways to enhance pet's well-being, presenting a holistic approach to pet care.
Furthermore, a worldwide study was conducted in 2021, which studied the gut microbiota in poultry worldwide. This Agrifutures Ag study acknowledged that the productivity of layer flocks relies on the gut microbiota and provided comprehensive data on the normal baseline composition of the gut microbiota in healthy layer poultry in cage, barn, and free-range systems.
Future research on gut health, such as an assessment of gut health therapies and techniques for expanding the duration of egg production and preserving egg quality during the lay, can be designed upon the findings of this project.
The industry leaders are encouraging research culture in this industry by investing in startups and other promising ongoing research studies to translate them into commercial animal well-being solutions. For example, in 2021, Cargill invested in a California, U.S.-based startup known as AnimalBiome. This company aims to develop solutions that can diagnose, restore, and maintain the gut health of companion animals like dogs, cats & horses. The company has thorough research backing of over 20 years in animal microbiome research. Such market developments portray a promising future for animal intestinal health.
Request a free sample copy or view report summary: Animal Intestinal Health Market Report
Based on animal type, the production animal segment held a dominant share of 75.23% in 2023. Increased consumption of meat and dairy products is a major factor driving the segment growth.
Based on product, the nutrition segment dominated the market in 2023, with a market share of 83.22%, and is anticipated to grow at a CAGR of 8.14% over the forecast period. This segment is further segmented into products like probiotics, prebiotics, postbiotics, phytogenics, enzymes, and immunomodulators.
Based on mode of delivery, the feed/water additives segment dominated the market in 2023, with a revenue share of over 60%. This can be attributed to the high palatability and animal compliance.
Based on function, the preventive care segment dominated the market in terms of revenue share in 2023 and is anticipated to witness the fastest CAGR over the forecast period. This can be attributed to the fact that products like probiotics, prebiotics, and immunomodulators are widely used in various nutritional regimes for animals like cattle, poultry, swine, dogs, cats, and horses.
Based on distribution channel, the animal farms segment dominated the market in terms of revenue share in 2023 owing to the high adoption of feed additives in these channels.
The Asia Pacific region held the largest global revenue share of over 30% in 2023 and is anticipated to witness the fastest growth over the years 2024-2030. This region is home to two of the world's largest animal husbandry producers, India and China. Together, these countries account for more than 40% of the world's cattle population. These factors will act as major driving factors for APAC.
Brazil's market for animal intestinal health is dominant and held the largest share in Latin America owing to its second-highest beef production after the U.S. According to 2024 data by USDA, Brazil produced over 10.95 million metric tons of beef (18% of global production).
Grand View Research has segmented the global animal intestinal health market based on animal type, product, mode of delivery, function, distribution channel & region:
Animal Intestinal Health Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Production Animal
Cattle
Swine
Poultry
Others (sheep, goats, aquaculture, etc.)
Companion Animal
Canine
Feline
Equine
Others (turtles, fish, rabbits, etc.)
Animal Intestinal Health Product Outlook (Revenue, USD Million, 2018 - 2030)
Nutrition
Probiotics
Prebiotics
Postbiotics
Phytogenics
Enzymes
Immunomodulators
Pharmaceuticals
Antibiotics
Others
Animal Intestinal Health Mode of Delivery Outlook (Revenue, USD Million, 2018 - 2030)
Feed/Water Additives
Supplements & Tablets
Other mode of delivery
Animal Intestinal Health Function Outlook (Revenue, USD Million, 2018 - 2030)
Preventive Care
Disease Treatment
Animal Intestinal Health Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Veterinary Hospitals/Clinics
Animal Farms
E-Commerce
Animal Specialty Stores
Other Distribution Channel
Animal Intestinal Health Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
India
China
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Animal Intestinal Health Market
Cargill
Evonik Industries
Kemin Industries
Alltech
dsm-firmenich (DSM)
Adisseo
Kerry Group plc.
Novozymes A/S
Karyotica Biologicals Pvt Ltd.
EW Nutrition
AB Vista
AdvaCarePharma
ADM
Zoetis
Boehringer Ingelheim
Dechra Pharmaceuticals
"The quality of research they have done for us has been excellent..."